ArticleJournal of cancer research and clinical oncology2016

Risk factors for outcome in refractory acute myeloid leukemia patients treated with a combination of fludarabine, cytarabine, and amsacrine followed by a reduced-intensity conditioning and allogeneic stem cell transplantation.

Christian Pfrepper et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.